We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Direct Buyers Win Cert. In Lamictal Antitrust Suit

Law360 (December 13, 2018, 3:38 PM EST) -- Drug wholesalers who directly purchased GlaxoSmithKline PLC's epilepsy drug Lamictal or a generic version from Teva Pharmaceutical Industries Ltd. won certification Wednesday in their antitrust suit alleging a settlement agreement struck...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.